Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,641,754
-
Share change
-
+11,956,342
-
Total reported value
-
$96,102,444
-
Price per share
-
$3.90
-
Number of holders
-
72
-
Value change
-
+$37,375,333
-
Number of buys
-
54
-
Number of sells
-
27
Institutional Holders of IMMUNE DESIGN CORP - COM (IMDZ) as of Q4 2017
As of 31 Dec 2017,
IMMUNE DESIGN CORP - COM (IMDZ) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,641,754 shares.
The largest 10 holders included
EcoR1 Capital, LLC, Bain Capital Public Equity Management, LLC, FRANKLIN RESOURCES INC, Versant Venture Management, LLC, BlackRock Inc., BVF INC/IL, Vanguard Group Inc, FMR LLC, JPMORGAN CHASE & CO, and Alyeska Investment Group, L.P..
This page lists
72
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.